Download the Mass Cytometry app note

Learn how the unique high-content proteomics capabilities of CyTOF technology can reveal predictive response, biomarker translation and mechanism of action in cancer immunotherapy clinical trials.

Please complete this form to be directed to a downloadable version of this app note.

It is critical for immunotherapy clinical trials to attain a comprehensive understanding of the immune response to disease and to potential treatment. This in-depth knowledge better enables accurate identification of predictive markers, biomarker translation and understanding mechanism of action, all of which are important for efficient and effective clinical trial execution. CyTOF™ technology is uniquely positioned to facilitate this level of understanding.